We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
3201
Cardiff Oncology
CRDF
$72.7M
$30K ﹤0.01%
333
-14
-4% -$902
SNGX icon
3202
Soligenix
SNGX
$5.59M
$30K ﹤0.01%
61
-1
-2% -$615
UEC icon
3203
Uranium Energy
UEC
$5.29B
$30K ﹤0.01%
19,000
-5,400
-22% -$7.54K
F icon
3204
CALL
Ford
F
$56.7B
$29K ﹤0.01%
157,500
-58,100
-27% -$649K
TTI icon
3205
TETRA Technologies
TTI
$1.23B
$29K ﹤0.01%
+10,331
New +$34.3K
VEEV icon
3206
CALL
Veeva Systems
VEEV
$34.4B
$29K ﹤0.01%
+11,800
New +$681K
NMM icon
3207
Navios Maritime Partners
NMM
$2.23B
$28K ﹤0.01%
1,191
-100
-8% -$2.69K
PEP icon
3208
CALL
PepsiCo
PEP
$189B
$28K ﹤0.01%
45,800
+2,000
+5% +$229K
SGU icon
3209
CALL
Star Group
SGU
$422M
$28K ﹤0.01%
+21,600
New +$213K
TNK icon
3210
Teekay Tankers
TNK
$2.61B
$28K ﹤0.01%
1,833
-1,437
-44% -$22.2K
VSTM icon
3211
Verastem
VSTM
$515M
$28K ﹤0.01%
+1,054
New +$26.8K
C icon
3212
CALL
Citigroup
C
$231B
$27K ﹤0.01%
12,000
-19,800
-62% -$1.21M
GSK icon
3213
CALL
GSK
GSK
$103B
$27K ﹤0.01%
52,720
+2,800
+6% +$149K
MVIS icon
3214
Microvision
MVIS
$77.8M
$27K ﹤0.01%
+835
New +$26.9K
OMC icon
3215
CALL
Omnicom Group
OMC
$22.5B
$27K ﹤0.01%
53,300
+26,800
+101% +$2.23M
KBE icon
3216
CALL
State Street SPDR S&P Bank ETF
KBE
$1.68B
$26K ﹤0.01%
25,100
+9,500
+61% +$404K
LOW icon
3217
CALL
Lowe's Companies
LOW
$122B
$26K ﹤0.01%
51,800
+600
+1% +$49K
ASXC
3218
DELISTED
Asensus Surgical, Inc.
ASXC
$26K ﹤0.01%
2,797
+1,065
+61% +$10.1K
CSCO icon
3219
CALL
Cisco
CSCO
$478B
$25K ﹤0.01%
175,800
+125,500
+250% +$4.09M
GROW icon
3220
US Global Investors
GROW
$37.1M
$25K ﹤0.01%
16,124
+616
+4% +$884
OPTT icon
3221
Ocean Power Technologies
OPTT
$50.3M
$25K ﹤0.01%
+935
New +$29.5K
HSBC icon
3222
CALL
HSBC
HSBC
$350B
$24K ﹤0.01%
15,322
-176
-1% -$6.83K
HWC icon
3223
CALL
Hancock Whitney
HWC
$6.3B
$24K ﹤0.01%
+14,600
New +$687K
SPY icon
3224
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$24K ﹤0.01%
29,200
+500
+2% +$120K
ESRX
3225
CALL
DELISTED
Express Scripts Holding Company
ESRX
$24K ﹤0.01%
21,800
+4,600
+27% +$289K
127 128
129
130 131

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.